Amniotic fluid embolism (AFE) is a rare but life-threatening condition during pregnancy with complex causes and serious consequences for both mother and infant, accompanied by high mortality rates. Diagnosis is challenging and often requires exclusion of other conditions, with symptoms including sudden respiratory distress and abnormal bleeding. Effective management involves aggressive treatment and monitoring, as maternal mortality can arise from cardiac arrest, hemorrhage, or respiratory failure.